Biotech Values

[dewophile]

Yes although w ovarian mets are generally very bulky so if you think pd-1 in this context is mainly targeting csc or mets that is perhaps why you are seeing low response rates
In front line surgical debulkimg is soc so perhaps the drug will perform better in this setting coupled w chemo